These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 31562001

  • 1. Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017.
    Chow EPF, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Regan DG, Hocking JS, Garland SM, Cornall AM, Atchison S, Bradshaw CS, McNulty A, Owen L, Marshall L, Russell DB, Kaldor JM, Chen MY.
    Vaccine; 2019 Oct 31; 37(46):6907-6914. PubMed ID: 31562001
    [Abstract] [Full Text] [Related]

  • 2. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
    Chow EPF, Machalek DA, Tabrizi SN, Danielewski JA, Fehler G, Bradshaw CS, Garland SM, Chen MY, Fairley CK.
    Lancet Infect Dis; 2017 Jan 31; 17(1):68-77. PubMed ID: 27282422
    [Abstract] [Full Text] [Related]

  • 3. Human Papillomavirus Prevalence in Unvaccinated Heterosexual Men After a National Female Vaccination Program.
    Machalek DA, Chow EP, Garland SM, Wigan R, Cornall AM, Fairley CK, Kaldor JM, Hocking JS, Williams H, McNulty A, Bell C, Marshall L, Ooi C, Chen MY, Tabrizi SN.
    J Infect Dis; 2017 Jan 15; 215(2):202-208. PubMed ID: 27815379
    [Abstract] [Full Text] [Related]

  • 4. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
    Goggin P, Sauvageau C, Gilca V, Defay F, Lambert G, Mathieu-C S, Guenoun J, Comète E, Coutlée F.
    Hum Vaccin Immunother; 2018 Jan 02; 14(1):118-123. PubMed ID: 29049007
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study.
    Chow EPF, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Garland SM, Cornall AM, Atchison S, Hocking JS, Bradshaw CS, Balgovind P, Murray GL, Chen MY.
    Lancet Infect Dis; 2021 Oct 02; 21(10):1448-1457. PubMed ID: 34043963
    [Abstract] [Full Text] [Related]

  • 6. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
    Garland SM, Cornall AM, Brotherton JML, Wark JD, Malloy MJ, Tabrizi SN, VACCINE study group.
    Vaccine; 2018 May 31; 36(23):3221-3230. PubMed ID: 29724506
    [Abstract] [Full Text] [Related]

  • 7. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
    Osborne SL, Tabrizi SN, Brotherton JM, Cornall AM, Wark JD, Wrede CD, Jayasinghe Y, Gertig DM, Pitts MK, Garland SM, VACCINE Study group.
    Vaccine; 2015 Jan 01; 33(1):201-8. PubMed ID: 25444787
    [Abstract] [Full Text] [Related]

  • 8. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
    Patel C, Brotherton JM, Pillsbury A, Jayasinghe S, Donovan B, Macartney K, Marshall H.
    Euro Surveill; 2018 Oct 01; 23(41):. PubMed ID: 30326995
    [Abstract] [Full Text] [Related]

  • 9. Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination.
    Machalek DA, Garland SM, Brotherton JML, Bateson D, McNamee K, Stewart M, Rachel Skinner S, Liu B, Cornall AM, Kaldor JM, Tabrizi SN.
    J Infect Dis; 2018 Apr 23; 217(10):1590-1600. PubMed ID: 29425358
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.
    Chow EP, Danielewski JA, Fehler G, Tabrizi SN, Law MG, Bradshaw CS, Garland SM, Chen MY, Fairley CK.
    Lancet Infect Dis; 2015 Nov 23; 15(11):1314-23. PubMed ID: 26201300
    [Abstract] [Full Text] [Related]

  • 11. Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian females.
    Subasinghe AK, Wark JD, Phillips S, Cornall A, Brotherton JML, Garland SM.
    Sex Health; 2020 Dec 23; 17(6):510-516. PubMed ID: 33341122
    [Abstract] [Full Text] [Related]

  • 12. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.
    Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Liu B, Bateson D, McNamee K, Garefalakis M, Phillips S, Cummins E, Malloy M, Garland SM.
    Lancet Infect Dis; 2014 Oct 23; 14(10):958-66. PubMed ID: 25107680
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs.
    Elfström KM, Lazzarato F, Franceschi S, Dillner J, Baussano I.
    J Infect Dis; 2016 Jan 15; 213(2):199-205. PubMed ID: 26142436
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of HPV After Introduction of the Vaccination Program in the United States.
    Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER.
    Pediatrics; 2016 Mar 15; 137(3):e20151968. PubMed ID: 26908697
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.